Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Salubris Bio
AddedFeb 15, 2024
UpdatedJun 18, 2026
Salubris Bio

Salubris Bio

SalubrisBio, a subsidiary of Salubris Pharmaceuticals, is a China-based biotech firm specializing in innovative R&D.

HQ
Gaithersburg, MD, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

SalubrisBio, founded in August 2016 as a subsidiary of China-based Salubris Pharmaceuticals Co. Ltd., is headquartered in Gaithersburg, Maryland. The company is dedicated to pioneering research and development in the biotech sector, focusing on creating innovative and transformative therapeutic molecules. SalubrisBio specializes in developing novel antibody and protein-based therapeutics aimed at providing significant clinical improvements for patients with unmet medical needs.

Notable affiliated individuals include key researchers and executives from both SalubrisBio and its parent company, Salubris Pharmaceuticals. The company has achieved several milestones in advancing its clinical-stage biotechnology programs. Its innovative approach has made a substantial impact on the biotech industry, particularly in addressing complex diseases with high unmet medical needs.

Salubris Bio - Similar Companies

Shenzhen Salubris Pharmaceuticals Co. logo

Shenzhen Salubris Pharmaceuticals Co.

AltruBio logo

AltruBio

Zebra Biologics logo

Zebra Biologics

Brii Biosciences logo

Brii Biosciences

briibio.com

SAB Biotherapeutics logo

SAB Biotherapeutics

sab.bio

Surf Bio logo

Surf Bio

surf.bio

Resolys Bio logo

Resolys Bio

Selva Therapeutics logo

Selva Therapeutics

RenBio logo

RenBio

renbio.com

Fabrus logo

Fabrus

fabrus.net

EpiBiologics logo

EpiBiologics

epibiologics.com

Salish Bioscience logo

Salish Bioscience

3SBio logo

3SBio

Conjupro Biotherapeutics logo

Conjupro Biotherapeutics

Creative BioTherapeutics logo

Creative BioTherapeutics

creativebio.tech

Salubris Bio - Quick Facts

Who are Salubris Bio's competitors?

Companies similar to Salubris Bio include Shenzhen Salubris Pharmaceuticals Co., AltruBio, Zebra Biologics and Brii Biosciences.

When was Salubris Bio founded?

Salubris Bio was founded in 2016.

Where is Salubris Bio's headquarters located?

Salubris Bio's headquarters is located in Gaithersburg, MD, US.

When was Salubris Bio's last funding round?

Salubris Bio's most recent funding round was for $35M (USD) in March 2023.

How much has Salubris Bio raised to-date?

As of Mar 28, 2023, Salubris Bio has raised a total of $67M (USD).

How many employees does Salubris Bio have?

Salubris Bio has 35 employees as of Feb 4, 2024.

Salubris Bio - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biotherapeutics
Tags
  • Healthtech
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified